Late excess mortality in essential thrombocythemia: a population-based study in the Netherlands, 2001-2018

Leukemia. 2022 Jan;36(1):275-278. doi: 10.1038/s41375-021-01372-5. Epub 2021 Aug 6.

Tom S M Posthuma¹, Otto Visser², Peter A W Te Boekhorst³, Avinash G Dinmohamed^{4

5

6

7}

¹ Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
² Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
³ Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, The Netherlands.
⁴ Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.
⁵ Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. a.dinmohamed@iknl.nl.
⁶ Erasmus MC, University Medical Center Rotterdam, Department of Public Health, Rotterdam, The Netherlands. a.dinmohamed@iknl.nl.
⁷ Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.

No abstract available

MeSH terms